<?xml version="1.0" encoding="UTF-8"?>
<p>During treatment with nivolumab and CIK cells, no adverse events occurred except for a fever of 38.8 Â°C at the beginning of therapy. This was managed with physical cooling treatment; no corticosteroids were given.</p>
